Atopic dermatitis

Janus kinase inhibitors are novel therapeutics for treating atopic dermatitis, and can be administered both orally or topically. This meta-analysis focuses on the safety and efficacy of oral janus kinase inhibitors. Atopic dermatitis (AD) is one of the most common inflammatory skin diseases, and its pathogenesis involves skin barrier disruption and immune activation of T-helper...

Janus kinase inhibitors are a novel form of treatment for atopic dermatitis and can be administered topically or systemically. This study focuses on a meta-analysis of topical use. Among the main contributing factors to the pathophysiology of atopic dermatitis (AD) is the dysregulation of innate and adaptive immune systems. Janus kinase inhibitors (JAKi) reduce the...

Learn to identify common triggers and implement proper skincare routines to reduce flare-ups and improve your overall quality of life. We’ll also discuss treatment options like medications, wet wrap therapy, and the importance of seeking professional medical advice. Atopic dermatitis is a chronic inflammatory skin condition that affects millions of people worldwide. Atopic dermatitis can...

In this MD Newsline webcast Dr. Pete Thomas and Dr. Joyce Imahiyerobo-Ip discuss atopic dermatitis in skin of color. Register here to view the webcast. Visit MDNewsline.com’s atopic dermatitis channel for more information on atopic dermatitis.

Nonmodifiable risk factors include gestational diabetes, maternal history of allergy, prenatal history of eczema Genetic and environmental prenatal risk factors play a role in early childhood atopic dermatitis (AD), according to a review published online Jan. 27 in the Annals of Dermatology. Hong Cui, M.D., Ph.D., from the First Teaching Hospital of Tianjin University of Traditional...

There is a potential risk of the development of vitiligo in pediatric atopic dermatitis patients owing to the Koebner phenomenon. Vitiligo is a skin disorder associated with the loss of melanin from normal skin regions. An abnormal inflammatory response in this disorder indicates a potential association between vitiligo and atopic dermatitis (AD). Pediatric AD may...

Based on a 2019 study, non-Hispanic Black and Hispanic children have higher rates of school absences due to AD. Atopic Dermatitis (AD), also known as eczema, is more severe in minority children, with Black children having a higher incidence rate than White or Hispanic children. Based on this 2019 study published in JAMA Dermatology, non-Hispanic...

According to this study, minorities are less likely to seek healthcare intervention for eczema despite having more severe cases. Eczema, also known as atopic dermatitis (AD), is a common chronic inflammatory disease of the skin. Based on information from this cohort study published in the Journal of American Academic Dermatology, in the United States, eczema...

Racial Inequity can add an additional financial burden to minority patients with atopic dermatitis. Reducing this burden can lead to better patient outcomes. The Financial Burden of Atopic Dermatitis Atopic dermatitis (AD), also known as eczema, is associated with direct and indirect costs because of its chronic nature. This condition is more prevalent in children...